RAC 2.92% $1.94 race oncology ltd

Ann: Positive Pre-IND Guidance from FDA on Zantrene, page-11

  1. 877 Posts.
    lightbulb Created with Sketch. 467
    It's significant as it's confirmation from the FDA that our activities to date and future planned activities are logical and in line with a smooth approval. Past blockers have also been cleared. It's not a massive announcement but just a good piece of assurance from one of the actors that are critical in getting our drug approved and commercialised.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.